Quarterly Activities/Appendix 4C Cash Flow Report
| Stock | MACH7 Technologies Ltd (M7T.ASX) |
|---|---|
| Release Time | 29 Jul 2025, 8:30 a.m. |
| Price Sensitive | Yes |
Mach7 Technologies Reports Q4 FY25 Results
- CARR of A$30.2M; ARR Run Rate of A$23.5M at 30 June 2025
- Q4 FY25 Sales orders of A$7.8M (TCV); FY25 Sales Orders of A$29.1M
- Operating cash flow positive in FY25 (A$0.7M) and Q4 FY25 (A$0.6M)
Mach7 Technologies Limited, a company specialising in innovative medical imaging software solutions, has provided a business update and quarterly cashflow report for the quarter ended 30 June 2025. The company recorded strong revenue growth, demonstrating the value of its products and solutions to customers. Operating costs were carefully managed, and OPEX growth will be less than revenue growth in line with FY25 guidance. Mach7 is in a strong financial position, with closing cash of A$23.1M and no debt, and the company delivered on its objective to be operating cash flow positive for the year. This provides a solid foundation for the company to move forward. In Q4 FY25, Mach7 recorded sales orders of A$7.8M (TCV), bringing the FY25 sales orders to A$29.1M. The majority of sales orders received were for ARR-type sales, representing 88% of the total. Mach7 is currently generating A$23.5M in ARR, with CARR of A$30.2M at 30 June 2025. The company was operating cash flow positive in Q4 FY25 for a third consecutive quarter, with operating cash inflows of A$0.6M, and also achieved its objective of being operating cash flow positive for FY25 (A$0.7M). Mach7 capitalised A$0.2M in development costs during the quarter, which largely related to an R&D project expected to deliver annualised cost savings of approximately A$1.0M when fully implemented. The company's leadership team has also undergone changes, with the appointment of Paul Jensen as Mach7's first Chief Innovation Officer.
Mach7 reaffirms its revised FY25 guidance for revenue of A$33M-$34M, CARR of approximately A$30M-$31M and for OPEX growth to be less than revenue growth.
In 1H FY26, Mach7's immediate priorities include the development of a comprehensive strategy following a thorough review of its operations, focusing on how the company can accelerate the delivery of innovation and a compelling customer value proposition.